News
2h
Health on MSNRoad to Diagnosis: Patients Share Their MASH JourneysYou might not think much about what makes a liver healthy or unhealthy. And when your liver starts to become unhealthy, you ...
On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...
10h
MyChesCo on MSNMadrigal Pharmaceuticals Reports Promising Two-Year Data for Rezdiffra in MASH CirrhosisCONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced two-year results from the open-label arm of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results